Molbio Diagnostics reported a major improvement in its financial performance, returning to profitability compared with a loss during the previous period.
The company reported a profit of around Rs.58.7 cr., compared with a loss of approximately Rs.23.7 cr. earlier. Revenue also recorded a sharp increase, rising to around Rs.408.4 cr. from Rs.99.7 cr.
The strong turnaround places the company in focus as investors assess whether the improvement in revenue and profitability can be sustained. Future quarterly performance will be important in determining whether the recent growth represents a long-term recovery.
